South Africa Endomyocardial Biopsy Market Size & Outlook
Related Markets
South Africa endomyocardial biopsy market highlights
- The South Africa endomyocardial biopsy market generated a revenue of USD 9.6 million in 2024 and is expected to reach USD 14.8 million by 2030.
- The South Africa market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
- In terms of segment, forceps was the largest revenue generating product in 2024.
- Forceps is the most lucrative product segment registering the fastest growth during the forecast period.
Endomyocardial biopsy market data book summary
| Market revenue in 2024 | USD 9.6 million |
| Market revenue in 2030 | USD 14.8 million |
| Growth rate | 7.4% (CAGR from 2025 to 2030) |
| Largest segment | Forceps |
| Fastest growing segment | Forceps |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Forceps, Accessories |
| Key market players worldwide | Argon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments |
Other key industry trends
- In terms of revenue, South Africa accounted for 2.6% of the global endomyocardial biopsy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa endomyocardial biopsy market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 14.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endomyocardial Biopsy Market Scope
Endomyocardial Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fehling Instruments | View profile | 11-50 | Karlstein, Bayern, Germany, Europe | https://www.fehling-instruments.de |
| Changzhou Lookmed Medical Instrument Co. | View profile | 51-100 | Changzhou, Zhejiang, China, Asia | http://www.lookmedchina.com |
| Scholten Surgical Instruments | View profile | 1-10 | Lodi, California, United States, North America | https://www.novatome.com |
| Argon Medical Devices | View profile | 1001-5000 | Plano, Texas, United States, North America | http://www.argonmedical.com/ |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
South Africa endomyocardial biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.
Forceps was the largest segment with a revenue share of 76.04% in 2024. Horizon Databook has segmented the South Africa endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.
The economic development of South Africa and the presence of high unmet healthcare needs are some of the primary growth drivers of this market. The expected growth in healthcare spending and increased demand for advanced healthcare treatments are anticipated to boost the market during the forecast period.
Healthcare facilities that have established a strong reputation for delivering high-quality patient care and achieving positive treatment outcomes are better positioned to draw in patients. Organizations that actively pursue research and advancements in the realm of cardiology and cardiac procedures can gain a competitive advantage.
They can provide state-of-the-art therapies and diagnostic methods. Forming partnerships and collaborations with pharmaceutical companies, manufacturers of medical devices, and academic institutions can confer a competitive edge. These alliances enable access to the latest research and cutting-edge technology.
Reasons to subscribe to South Africa endomyocardial biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa endomyocardial biopsy market databook
-
Our clientele includes a mix of endomyocardial biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa endomyocardial biopsy market , including forecasts for subscribers. This country databook contains high-level insights into South Africa endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa endomyocardial biopsy market size, by product, 2018-2030 (US$M)
South Africa Endomyocardial Biopsy Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
